Hartree Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-790,000
Closed -$6.04M 79
2024
Q3
$6.04M Sell
790,000
-800,000
-50% -$7.37M 1.39% 19
2024
Q2
$16.5M Buy
1,590,000
+173,400
+12% +$1.9M 4.12% 10
2024
Q1
$16.9M Buy
1,416,600
+189,708
+15% +$2.11M 4.38% 6
2023
Q4
$13.3M Buy
+1,226,892
New +$14.9M 4.79% 5

Other funds holding PTEN

Hartree Partners's PTEN Position: Q4 2024 in Review

Hartree Partners sold out of Patterson-UTI (PTEN) in Q4 2024, closing a stake of 790,000 shares — an estimated $6.04M sold.

Hartree Partners first reported a position in PTEN in Q4 2023 and held it in 4 quarters. The position peaked at $16.9M in Q1 2024. 365 funds tracked by Wall St. Rank hold PTEN as of Q4 2024.

  • Hartree Partners reported no remaining Patterson-UTI position as of Q4 2024 after selling out during the quarter.
  • Hartree Partners sold 790,000 Patterson-UTI shares in Q4 2024, an estimated $6.04M.
  • Hartree Partners first reported a position in Patterson-UTI in Q4 2023 and held it in 4 quarters.
  • Hartree Partners's Patterson-UTI position peaked at $16.9M in Q1 2024.
  • 365 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2024.

Based on Hartree Partners's 13F filing for Q4 2024, filed 12 Feb 2025.